'I had anti-government views so they treated me for schizophrenia'
The issue has been acknowledged by China's government - the country's 2013 Mental Health Law aimed to stop this abuse, making ...
AbbVie CEO says psychiatric drug space challenging, more cautious on investments
AbbVie will commit less capital towards experimental medicines for psychiatric disease, CEO Robert Michael said at an ...
NBC Los Angeles11d
Bristol Myers Squibb CEO describes new drug for treating schizophrenia
Bristol Myers Squibb CEO Chris Boerner described Cobenfy, a new drug to treat schizophrenia and may also help with bipolar ...
Blockbuster weight-loss drugs linked to lower risk of addiction, schizophrenia, dementia, and more
While weight-loss drugs were linked to lower risk of some conditions, they were also associated with some adverse health ...
Crain's Chicago Business8d
Despite $3.5B impairment charge on failed Cerevel drug, AbbVie still sees potential
The schizophrenia drug Emraclidine failed to perform in clinical trials but executives say it can still “play a role.” ...
KOMU8d
FDA approves first new schizophrenia drug in more than 30 years
The FDA has approved Cobenfy, a new drug to treat people with schizophrenia that comes with fewer side effects.
Weight-Loss Drugs Like Ozempic Linked To Lower Risk Of 42 Conditions
Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took ...
Becker's Hospital Review10d
AbbVie to write off $3.5B over failed Schizophrenia drug
AbbVie will write off $3.5 billion related to its $8.7 billion investment in Cerevel Therapeutics following the failure of the company's key schizophrenia drug, emraclidine, The Wall Street Journal ...
Sun Star3d
Son who killed father tests negative for drugs
The suspect in the brutal murder of his father in Tagum City has tested negative for drugs. However, a psychiatric evaluation ...